Is Plains GP Holdings’ Acquisition and Divestiture Strategy Reframing the PAGP Investment
November 6, 2025
-
Plains GP Holdings reported third-quarter 2025 results on November 5, 2025, with sales of US$11.58 billion and a net income increase to US$83 million, though both earnings and revenue came in below analyst expectations.
-
Despite revenue declines, the company announced it completed the acquisition of EPIC Crude Holdings and is divesting its Canadian natural gas liquids business to focus on core crude oil midstream operations.
-
We’ll examine how Plains GP Holdings’ underwhelming earnings combined with its recent acquisition and divestiture shape its investment narrative.
Trump has pledged to “unleash” American oil and gas and these 22 US stocks have developments that are poised to benefit.
Owning Plains GP Holdings means believing in the long-term strength of U.S. crude oil midstream infrastructure and resilience through commodity cycles. While third-quarter 2025 results fell short of forecasts, the recent EPIC Crude Holdings acquisition and planned NGL divestiture have not materially changed the business’s biggest near-term catalyst, reinvesting sale proceeds for growth and buybacks, or its biggest risk, which remains outsized exposure to crude demand and contract repricing.
The most relevant announcement is the completed EPIC Crude Holdings acquisition, which scales Plains’ core midstream platform just as the company exits less strategic segments. This move supports the catalyst to concentrate assets in the Permian Basin, potentially boosting long-term throughput and margins, while also tying future performance more tightly to regional crude oil trends.
However, despite higher net income this quarter, the risk from increased concentration and any downturn in North American crude volumes is something investors should keep in mind if …
Read the full narrative on Plains GP Holdings (it’s free!)
Plains GP Holdings is expected to generate $49.0 billion in revenue and $417.5 million in earnings by 2028, based on analyst forecasts. This projection reflects an annual revenue decline of 0.9% and a $445.5 million increase in earnings from the current level of -$28.0 million.
Uncover how Plains GP Holdings’ forecasts yield a $20.62 fair value, a 20% upside to its current price.
Six unique community valuations for Plains GP Holdings range from US$18.50 up to US$111.07, illustrating broad differences in outlook among Simply Wall St Community members. While many are focused on potential gains from the shift to asset concentration, remember that heightened exposure to North American crude still shapes the outlook and warrants careful consideration of future earnings resilience.
Explore 6 other fair value estimates on Plains GP Holdings – why the stock might be worth over 6x more than the current price!
Disagree with existing narratives? Create your own in under 3 minutes – extraordinary investment returns rarely come from following the herd.
-
A great starting point for your Plains GP Holdings research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
-
Our free Plains GP Holdings research report provides a comprehensive fundamental analysis summarized in a single visual – the Snowflake – making it easy to evaluate Plains GP Holdings’ overall financial health at a glance.
Markets shift fast. These stocks won’t stay hidden for long. Get the list while it matters:
-
AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10b in market cap – there’s still time to get in early.
-
The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer’s.
-
We’ve found 20 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include PAGP.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Search
RECENT PRESS RELEASES
Related Post
